4,580
Views
11
CrossRef citations to date
0
Altmetric
Original Articles

A parallel, randomized, double-blind, placebo-controlled study to investigate the effect of SagaPro on nocturia in men

, , , &
Pages 26-32 | Received 10 Feb 2012, Accepted 16 May 2012, Published online: 02 Jul 2012

References

  • Staskin D, Kelleher C, Avery K, Bosch R, Cotterill N, Coyne K, Initial assessment of urinary and faecal incontinence in adult male and female patients. In Abrams P, Cardozo L, Khoury S, Wein A, editors. Incontinence. 4th ed. Plymouth: Health Publications; 2009.
  • Tikkinen KA, Johnson TM, Tammela TL, Sintonen H, Haukka J, Huhtala H, Nocturia frequency, bother, and quality of life: how often is too often? A population-based study in Finland. Eur Urol 2010;57:488–96.
  • Chartier-Kastler E, Tubaro A. The measurement of nocturia and its impact on quality of sleep and quality of life in LUTS/BPH. Eur Urol Suppl 2006;5:3–11.
  • Weiss JP, Blaivas JG. Nocturia. J Urol 2000;163:5–12.
  • Udo Y, Nakao M, Honjo H, Ukimura O, Kawauchi A, Kitakoji H, Analysis of nocturia with 24-h urine volume, nocturnal urine volume, nocturnal bladder capacity and length of sleep duration: concept for effective treatment modality. BJU Int 2011;107:791–8.
  • Weiss JP, Blaivas JG, Stember DS, Chaikin DC. Evaluation of the etiology of nocturia in men: the nocturia and nocturnal bladder capacity indices. Neurourol Urodyn 1999;18:559–65.
  • Walmsley K, Staskin DR. Nocturia: when is it not related to overactive bladder? Curr Urol Rep 2003;4:441–5.
  • Mariappan P, Turner KJ, Sothilingam S, Rajan P, Sundram M, Stewart LH. Nocturia, nocturia indices and variables from frequency–volume charts are significantly different in Asian and Caucasian men with lower urinary tract symptoms: a prospective comparison study. BJU Int 2007;100:332–6.
  • Burton C, Weiss JP, Parsons M, Blaivas JG, Coats AC. Reference values for the nocturnal bladder capacity index. Neurourol Urodyn 2011;30:52–7.
  • Sigurdsson S, Ogmundsdottir HM, Gudbjarnason S. Antiproliferative effect of Angelica archangelica fruits. Z Naturforsch C 2004;59:523–7.
  • Sigurdsson S, Ogmundsdottir HM, Gudbjarnason S. The cytotoxic effect of two chemotypes of essential oils from the fruits of Angelica archangelica L. Anticancer Res 2005;25:1877–80.
  • Härmälä P, Vuorela H, Törnquist K, Hiltunen R. Choice of solvent in the extraction of Angelica archangelica roots with reference to calcium blocking activity. Planta Med 1992;58:176–83.
  • Halldórsson B. Grasnytjar. Copenhagen: August Friedrich Stein; 1783.
  • Bjarnason AH. Íslensk flóra með litmyndum. Reykjavík: Iðunn; 1983.
  • Newall CA, Anderson LA, Phillipson JD. Herbal medicines – a guide for health-care professionals. London: Pharmaceutical Press; 1996.
  • Sigurdsson S, Ogmundsdottir HM, Hallgrimsson J, Gudbjarnason S. Antitumour activity of Angelica archangelica leaf extract. In Vivo 2005;19:191–4.
  • Piper PJ. Leukotrienes: possible mediators in bronchial asthma. Eur J Respir Dis Suppl 1983;129:45–64.
  • Bjorling DE, Saban MR, Bruskewitz RC, Saban R. Response of the isolated guinea pig bladder to exogenous and endogenous leukotrienes. J Urol 1994;152:1281–6.
  • Yoshimura N, Chancellor MB. Interstitial cystitis and bladder research: progress and future directions: highlights of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the Interstitial Cystitis Association (ICA) International Research Symposium October 19–20, 2000, Minneapolis, MN. Rev Urol 2001;3:146–51.
  • Scheuermaier K, Meyers M, Surprise M, Loughlin KR, Duffy JF. Reciprocal relationship between age-related sleep disruption and urological symptoms. BJU Int 2011;107:871–3.